Correction to: Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Their Use and Differential Features.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
Works matching IS 11732563 AND DT 2019 AND VI 39 AND IP 10
Results: 12
1
2
Mecapegfilgrastim in Chemotherapy-Induced Neutropenia: A Profile of Its Use in China.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 10, p. 1009, doi. 10.1007/s40261-019-00836-y
- By:
- Publication type:
- Article
3
Bronchodilator Efficacy of a Single-Dose 12/400-µg Formoterol/Budesonide Combination as a Dry Powder for Inhalation Delivered by Discair<sup>®</sup> in Adult Patients with Moderate-to-Severe Stable COPD: Open-Label, Single-Arm, Phase IV Trial.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 10, p. 991, doi. 10.1007/s40261-019-00828-y
- By:
- Publication type:
- Article
4
Cost-effectiveness Analysis of Pembrolizumab Plus Axitinib Versus Sunitinib in First-line Advanced Renal Cell Carcinoma in China.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 10, p. 931, doi. 10.1007/s40261-019-00820-6
- By:
- Publication type:
- Article
5
Cost-Effectiveness Analysis of Erenumab Versus OnabotulinumtoxinA for Patients with Chronic Migraine Attacks in Greece.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 10, p. 979, doi. 10.1007/s40261-019-00827-z
- By:
- Publication type:
- Article
6
Pharmacokinetic/Pharmacodynamic Evaluation of Dexlansoprazole Infusion Injection Compared with Lansoprazole in Healthy Chinese Adults.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 10, p. 953, doi. 10.1007/s40261-019-00824-2
- By:
- Publication type:
- Article
7
Dabrafenib Plus Trametinib for BRAF V600E-Mutant Non-small Cell Lung Cancer: A Patient Case Report.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 10, p. 1003, doi. 10.1007/s40261-019-00823-3
- By:
- Publication type:
- Article
8
HR+/HER2− Metastatic Breast Cancer: Epidemiology, Prescription Patterns, Healthcare Resource Utilisation and Costs from a Large Italian Real-World Database.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 10, p. 945, doi. 10.1007/s40261-019-00822-4
- By:
- Publication type:
- Article
9
Different Clopidogrel Response Elicited by Lansoprazole or Esomeprazole in Patients Undergoing Neurointervention with Dual Antiplatelet Therapy.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 10, p. 939, doi. 10.1007/s40261-019-00821-5
- By:
- Publication type:
- Article
10
Effect of DS-8500a, a Novel G Protein-Coupled Receptor 119 Agonist, on the Pharmacokinetics of Rosuvastatin and Atorvastatin in Healthy Subjects.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 10, p. 967, doi. 10.1007/s40261-019-00825-1
- By:
- Publication type:
- Article
11
Oral Contraceptives and Neutropenia: A Population-Based Cohort Study.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 10, p. 927, doi. 10.1007/s40261-019-00818-0
- By:
- Publication type:
- Article
12
Meta-analysis of Dropout Rates in Placebo-Controlled Randomized Clinical Trials of Atypical Antipsychotics Assessed by PANSS.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 10, p. 917, doi. 10.1007/s40261-019-00813-5
- By:
- Publication type:
- Article